title: Management of postmenopausal osteoporosis.
abstract: More than 25% of postmenopausal women are at risk of osteoporosis. In order to avoid its consequences, it is necessary to find an appropriate prevention and/or treatment. We studied: (1) 15 postmenopausal women treated with percutaneous estradiol (50 micrograms/24 h) plus MPA (10 mg/10 days/month); (2) 15 postmenopausal women treated with synthetic calcitonin nasal spray at the daily dose of 100 IU; (3) 10 postmenopausal women treated with nandrolone decanoate (50 mg every 3 weeks); (4) 10 postmenopausal women treated with ipriflavone (600 mg/day); and (5) 10 postmenopausal women treated with sodium fluoride (20 mg) plus calcium (600 mg). Clinical examination, bone mass measurement (total BMD), hematochemical and urinary parameters of bone metabolism (calcium, urinary hydroxyproline, PTH) and growth factors (as IGF-I and TNF-beta) were evaluated. After 6 months of therapy, a complete prevention of bone resorption was achieved. In agreement with current literature, we observed that the various therapeutic approaches have all some positive effect on BMD, with different results on pain, blood biochemical parameters and growth factors' concentrations.
authors.affiliation: Institute of Obstetrics and Gynecology, University of Perugia, Italy.
authors.forename: G C
authors.initials: GC
authors.lastname: Di Renzo
authors.forename: G
authors.initials: G
authors.lastname: Coata
authors.forename: E V
authors.initials: EV
authors.lastname: Cosmi
authors.forename: G B
authors.initials: GB
authors.lastname: Melis
authors.forename: L
authors.initials: L
authors.lastname: Maietta
authors.forename: A
authors.initials: A
authors.lastname: Volpe
mesh_terms: D000368:Aged; D015519:Bone Density; D016723:Bone Remodeling; D002116:Calcitonin / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*; D012307:Risk Factors
chemical_list: D002116:Calcitonin